Oxford University 'delighted' over gene therapy results

Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.

Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.

The Oxford University team are delighted with the results. Credit: ITV News

The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.

Advertisement

Groundbreaking gene therapy restores vision to two men

Groundbreaking gene therapy has restored vision to two men with a rare inherited eye disease who were expected to go blind.